NASDAQ:SABSW

Sab Biotherapeutics Stock Forecast

etoro logo Buy SABSW
*Your capital is at risk
$0.0100
-0.0003 (-2.91%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of SABSW AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add SABSW to Watchlist?
  • Easy Tracking In The Watchlist
PDF

High volatility in Sab Biotherapeutics, Inc. stock price on Thursday which ended trading at $0.0100
(Updated on Jun 18, 2026)

Hold candidate since Jun 18, 2026

The Sab Biotherapeutics, Inc. stock price fell by -2.91% on the last day (Thursday, 18th Jun 2026) from $0.0103 to $0.0100. During the last trading day the stock fluctuated 511.54% from a day low at $0.0078 to a day high of $0.0477. The price has fallen in 5 of the last 10 days and is down by -29.58% for this period. Volume has increased on the last day by 56 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 56 thousand shares were bought and sold for approximately $556.35 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -44.02% during the next 3 months and, with a 90% probability hold a price between $0.0021 and $0.0126 at the end of this 3-month period.

SABSW Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sab Biotherapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0118 and $0.0169. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 07, 2026, and so far it has fallen -67.43%. Further fall is indicated until a new bottom pivot has been found. Sab Biotherapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Sab Biotherapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0399 between high and low, or 511.54%. For the last week, the stock has had daily average volatility of 240.05%.

Our recommended stop-loss: $0.0095 (-5.34%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 29 days ago.)

Trading Expectations (SABSW) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Sab Biotherapeutics, Inc. to open at $0.0218, and during the day (based on 14 day Average True Range), to move between $0.0013 and $0.0187, which gives a possible trading interval of +/-$0.0174 (+/-1 331.45%) up or down from last closing price. If Sab Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 1 331.45% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.

With no support below and resistance from accumulated volume @ $0.0103, some $0.0003 (3.00%) from the current price of $0.0100, our system finds the risk reward not very attractive.

Is Sab Biotherapeutics, Inc. stock A Buy?

Sab Biotherapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $0.0218 ( 118.33%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

SABSW Performance

Trading levels for SABSW

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0617 517.33%
R2 0.0465 364.92%
R1 0.0371 270.75%
Price 0.0100
S1 0.0066 -34.08%
S2 -0.0028 -128.25%
S3 -0.0181 -280.67%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0124 24.00%
R2 0.0120 20.00%
R1 0.0103 3.00%
Price 0.0100
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Sab Biotherapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Sab Biotherapeutics, Inc. is SABSW and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Sab Biotherapeutics, Inc. Stock?
Sab Biotherapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Sab Biotherapeutics, Inc. Stock?
Sab Biotherapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sab Biotherapeutics, Inc. Stock.

What's the current price of Sab Biotherapeutics, Inc. Stock?
As of the end of day on the Jun 18, 2026, the price of an Sab Biotherapeutics, Inc. (SABSW) share was $0.0100.

What is the 52-week high and low for Sab Biotherapeutics, Inc. Stock?
The 52-week high for Sab Biotherapeutics, Inc. Stock is $0.130 and the 52-week low is $0.0078.

What is the market capitalization of Sab Biotherapeutics, Inc. Stock?
As of the Jun 18, 2026, the market capitalization of Sab Biotherapeutics, Inc. is 95.582K.

When is the next earnings date for Sab Biotherapeutics, Inc.?
The upcoming earnings date for Sab Biotherapeutics, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE